155 related articles for article (PubMed ID: 36657849)
1. Fucoidan from Fucus vesiculosus prevents the loss of dopaminergic neurons by alleviating mitochondrial dysfunction through targeting ATP5F1a.
Xing M; Li G; Liu Y; Yang L; Zhang Y; Zhang Y; Ding J; Lu M; Yu G; Hu G
Carbohydr Polym; 2023 Mar; 303():120470. PubMed ID: 36657849
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.
Mathew L; Burney M; Gaikwad A; Nyshadham P; Nugent EK; Gonzalez A; Smith JA
Integr Cancer Ther; 2017 Dec; 16(4):572-584. PubMed ID: 29096568
[TBL] [Abstract][Full Text] [Related]
4. Anti-Metabolic Syndrome Effects of Fucoidan from
Wang X; Shan X; Dun Y; Cai C; Hao J; Li G; Cui K; Yu G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547311
[TBL] [Abstract][Full Text] [Related]
5. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
6. Fucoidans of Brown Algae: Comparison of Sulfated Polysaccharides from
Usov AI; Bilan MI; Ustyuzhanina NE; Nifantiev NE
Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286461
[TBL] [Abstract][Full Text] [Related]
7. Alpha-amylase and alpha-glucosidase inhibition is differentially modulated by fucoidan obtained from Fucus vesiculosus and Ascophyllum nodosum.
Kim KT; Rioux LE; Turgeon SL
Phytochemistry; 2014 Feb; 98():27-33. PubMed ID: 24388677
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract][Full Text] [Related]
9. Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease.
Wang XL; Feng ST; Wang YT; Zhang NN; Guo ZY; Yan X; Yuan YH; Wang ZZ; Chen NH; Zhang Y
Phytomedicine; 2022 Sep; 104():154281. PubMed ID: 35752080
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan Inhibition of Osteosarcoma Cells Is Species and Molecular Weight Dependent.
Gupta D; Silva M; Radziun K; Martinez DC; Hill CJ; Marshall J; Hearnden V; Puertas-Mejia MA; Reilly GC
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32046368
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida.
Alghazwi M; Smid S; Karpiniec S; Zhang W
Int J Biol Macromol; 2019 Feb; 122():255-264. PubMed ID: 30401646
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
13. Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
Liu X; Liu W; Wang C; Chen Y; Liu P; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Physiol Behav; 2021 Oct; 239():113510. PubMed ID: 34181930
[TBL] [Abstract][Full Text] [Related]
14. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
15. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
Min SK; Kwon OC; Lee S; Park KH; Kim JK
Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.
Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P
Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712
[TBL] [Abstract][Full Text] [Related]
17. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
18. Size-dependent pharmacological activities of differently degraded fucoidan fractions from Fucus vesiculosus.
Lahrsen E; Schoenfeld AK; Alban S
Carbohydr Polym; 2018 Jun; 189():162-168. PubMed ID: 29580394
[TBL] [Abstract][Full Text] [Related]
19. N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease.
Xu B; Wang X; Xu Z; Li Q; Quan J
Neurosci Lett; 2022 Jul; 784():136751. PubMed ID: 35738458
[TBL] [Abstract][Full Text] [Related]
20. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
